Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis

International Braz J Urol

Volumn 34, Issue 4, 2008, Pages 503-511

  Soler, Roberto ^a   Bruschini, Homero ^a,c   Truzzi, Jose C ^a   Martins, Joao R ^a   Camara, Niels O ^a   Alves, Maria T ^a   Leite, Katia R ^b   Nader, Helena B ^b   Srougi, Miguel ^b   Ortiz, Valdemar ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c University of Sao Paulo ^*  (Brazil)

Author keywords

Cystitis; Dimethyl sulfoxide; Glycosaminoglycans; Protamines; Rats

Indexed keywords

EID: 56349124736     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382008000400013     Document Type: Article

References (20)

1. Driscoll A, Teichman JM: How do patients with interstitial cystitis present? J Urol. 2001; 166: 2118-20.
2. Rössberger J, Fall M, Peeker R: Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005; 39: 73-7.
3. Dietrich CP, Sampaio LO, Toledo OM: Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria. Biochem Biophys Res Commun. 1976; 71: 1-10.
4. Parsons CL, Lilly JD, Stein P: Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis).J Urol. 1991; 145: 732-5.
5. Fraser MO, Chuang YC, Lavelle JP, Yoshimura N, de Groat WC, Chancellor MB: A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride. Urology. 2001; 57: 112.
6. Westropp JL, Buffington CA: In vivo models of interstitial cystitis. J Urol. 2002; 167: 694-702.
7. Peterson MW, Gruenhaupt D: Protamine interaction with the epithelial cell surface. J Appl Physiol. 1992; 72: 236-41.
8. Martins JR, Passerotti CC, Maciel RM, Sampaio LO, Dietrich CP, Nader HB: Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients. Anal Biochem. 2003; 319: 65-72.
9. Dietrich CP, Dietrich SM: Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers. Anal Biochem. 1976; 70: 645-7.
10. Lavelle J, Meyers S, Ramage R, Bastacky S, Doty D, Apodaca G, et al.: Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol. 2002; 283: F242-53.
11. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ: Abnormal expression of molecular markers for bladder impermeability and differentiation in the urotheliurn of patients with interstitial cystitis. J Urol. 2004; 171: 1554-8.
12. Rosamilia A, Igawa Y, Higashi S: Pathology of interstitial cystitis. Int J Urol. 2003; 10 (Suppl): S11-5.
13. Parcell S: Sulfur in human nutrition and applications in medicine. Altern Med Rev. 2002; 7: 22-44.
14. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C: Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular spects. Biochemn Pharmacol. 2003; 65: 1035-41.
15. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H: Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol. 1990; 143: 139-42.
16. Laurent C, Hellström S, Engstrm-Laurent A, Wells AF, Bergh A: Localizationand quantity of hyaluronan in urogenital organs of male and female rats. Cell Tissue Res. 1995; 279: 241-8.
17. Akçay T, Konukoglu D: Glycosaminoglycans excretion in interstitial cystitis. Int Urol Nephrol. 1999; 31: 431-5.
18. Lokeshwar VB, Selzer MG, Cerwinka WH, Gomez MF, Kester RR, Bejany DE, et al.: Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity. J Urol. 2005; 174: 344-9.
19. Lokeshwar VB, Selzer MG, Unwala DJ, Estrella V, Gomez, MF, Golshani R, et al.: Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. J Urol. 2006; 176: 1001-7.
20. Taylor KR, Gallo RL: Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006; 20: 9-22.